JNJ241115C135000
- 25.00
- 0.000.00%
Johnson & Johnson Newsroom
Income Investing: Cast a Wider Net With These High-Yield Dividend Aristocrats -- Barron's
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
U.S. Pharma Is Largely Immune From 'MAHA' Impact: Wolfe
Johnson & Johnson (JNJ) Guggenheim Global Healthcare Conference (Transcript)
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says
This Is What Whales Are Betting On Johnson & Johnson
Market Falls Friday After Light Earnings and 13F's | Live Stock
Express News | CHMP Recommends Approval Of Janssen's Rybrevant (Amivantamab) And Lazcluze (Lazertinib) Combo For First-Line Treatment Of EGFR-Mutated Advanced NSCLC, Potentially Establishing New Standard Of Care Pending European Commission Approval
Least Shorted S&P 500 Stocks in October
This Johnson & Johnson Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Express News | EMA's Chmp: Lazcluze (Lazertinib) Received a Positive Opinion
Johnson & Johnson Initiated at Outperform by Wolfe Research
Johnson & Johnson Analyst Ratings
Vaccines stocks in the usa collectively plummet! Trump surprisingly appoints an anti-vaccine advocate as the Secretary of Health in the usa.
① Trump nominated Robert F. Kennedy Jr. as the new Secretary of Health and Human Services, which triggered a sell-off in vaccine companies; ② Kennedy advocates very radical views, opposing vaccines since 2005, and questioning the transparency of the usa government in public health information.
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower
Vaccines Makers Close Lower on Reports RFK Jr May Head HHS
Market Falls Thursday, Powell Said Fed Will Take Things Slow | Wall Street Today
Wolfe Research Upgrades Johnson & Johnson(JNJ.US) to Buy Rating, Raises Target Price to $190